Skip to content

Investment Case

  1. Revolutionising respiratory outcomes with a reliable and economically efficient solution

  2. Fast growing and emerging market allowing for a scalable solutions with international approval

  3. Technologically advanced solution with an attractive recurring revenue business model supported by strong IP protection

  4. Significant expansion opportunities in Ireland and Internationally with clear roadmap in place


Myles Murray, CEO

If you have more general investor related enquires, please contact us via: